Covered recipient · General Payments record
STEFAN R HUBER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$818.36
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $540.29 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $161.66 | 10 |
| Lilly USA, LLC | $65.97 | 4 |
| PFIZER INC. | $65.46 | 3 |
| Corium, Inc. | $64.92 | 3 |
| GlaxoSmithKline, LLC. | $54.43 | 3 |
| Acerta Pharma LLC | $38.82 | 2 |
| Tris Pharma Inc | $33.99 | 2 |
| BETA BIONICS, INC. | $20.30 | 1 |
| DEXCOM, INC. | $19.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $19.70 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104198639 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.12 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104323280 | CMS |
| BETA BIONICS, INC. | $20.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087882845 | CMS |
| Corium, LLC | $24.67 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100190801 | CMS |
| Corium, LLC | $22.25 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100184395 | CMS |
| Corium, LLC | $18.00 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100215933 | CMS |
| Dexcom, Inc. | $19.17 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153337751 | CMS |
| GlaxoSmithKline, LLC. | $16.96 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116132497 | CMS |
| GlaxoSmithKline, LLC. | $15.05 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116234675 | CMS |
| GlaxoSmithKline, LLC. | $22.42 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116126545 | CMS |
| Lilly USA, LLC | $17.00 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135399621 | CMS |
| Lilly USA, LLC | $17.19 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135415583 | CMS |
| Lilly USA, LLC | $14.94 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135399623 | CMS |
| Lilly USA, LLC | $16.84 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349764 | CMS |
| Novo Nordisk Inc | $17.32 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097028265 | CMS |
| Novo Nordisk Inc | $4.89 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097101379 | CMS |
| Novo Nordisk Inc | $19.43 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096866233 | CMS |
| Novo Nordisk Inc | $18.96 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097776196 | CMS |
| Novo Nordisk Inc | $24.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096982704 | CMS |
| Novo Nordisk Inc | $23.61 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096686916 | CMS |
| Novo Nordisk Inc | $17.23 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892185 | CMS |
| Novo Nordisk Inc | $8.66 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097352674 | CMS |
| Novo Nordisk Inc | $5.80 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096796061 | CMS |
| Novo Nordisk Inc | $21.12 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096747579 | CMS |
| PFIZER INC. | $19.72 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131913351 | CMS |
| PFIZER INC. | $20.63 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001571 | CMS |
| PFIZER INC. | $25.11 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131187046 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137581262 | CMS |
| Tris Pharma Inc | $18.72 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147243389 | CMS |
| Tris Pharma Inc | $15.27 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147243387 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.